Moderne medikamentöse Therapie des Typ-2-Diabetes
Authors:
- 25 November 2014
- journal article
- editorial
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 139 (49) , 2494-2497
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add‐on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metforminDiabetes, Obesity and Metabolism, 2014
- Risk of pancreatitis in patients treated with incretin-based therapiesDiabetologia, 2014
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 2013
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 DiabetesNew England Journal of Medicine, 2013
- A Comparative Study of the Effects of a Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability in Patients with Type 2 Diabetes with Inadequate Glycemic Control on MetforminDiabetes Technology & Therapeutics, 2013
- A Critical Analysis of the Clinical Use of Incretin-Based TherapiesDiabetes Care, 2013
- Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week ExtensionThe Journal of Clinical Endocrinology & Metabolism, 2013
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2012
- Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical ImplicationsThe American Journal of Medicine, 2011
- The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approachDiabetes/Metabolism Research and Reviews, 2010